This Master Class program was held on Saturday, November 1, 2014 in Panama city, Panama as part of a global initiative of the Physicians’ Academy for Cardiovascular Education (PACE) foundation with a particular focus on issues and opportunities in cardiovascular risk and lipid management in high risk patients.
 

Educational objectives

The overall educational objectives of the Cardiovascular Risk Master Class were:

• To review the epidemiology and current guidelines on the diagnosis, management, and treatment of patients at increased CV risk in Latin America
• To review new data on the pathophysiology of coronary artery disease and stroke and its relevance to treatment strategies and outcomes.
• To understand the medical need for intensive lipid and hypertension management in patients at high CV risk, such as DM and metabolic syndrome.
• To understand the pharmacologic and clinical rationale for various treatment options in the patients with increased CV risk and integrate scientific evidence from key clinical trials into clinical practice.
• Develop a consensus on practical guidelines for day-to-day management of high risk patients 

   

Funding

The conference is sponsored by an unrestricted educational grant provided by Pfizer.

View actual recordings of lectures (separate passcode needed)

 

CV Risk Master Class Panama

View the lectures held during the Cardiovascular Risk Master Class held on NOvember 1, 2014, in Panama

View & Download the teaching slides

 

Cardiovascular disease in Latin America: What are the issues and opportunities?

Presentation prepared and held by Raul Santos, MD, Sao Paulo, Brazil
 

CV risk & guidelines: A novel early intervention strategy to prevent cardiovascular disease

Presentation prepared and held by prof. John E Deanfield
 

Latest insights from lipid trials: What are the lessons for clinical practice?

Presentation prepared and held by dr Kees Hovingh, Amsterdam
 

The role of BP management in addressing CVD & stroke: Evolving therapeutic insights

Presentation prepared and held by prof. Kausik Ray, London
 

The diabetic patient and cardiovascular risk: Update on best strategies for prevention

Presentation prepared and held by Prof Kausik Ray,London
 

Non alcoholic fatty liver disease and atherosclerosis

Presentation prepared and held by Raul Santos, MD, Sao Paulo, Brazil
 

Evolving new therapies for the prevention of atherosclerosis: A glimpse of the near future

Presentation prepared and held by Dr Kees Hovingh, Amsterdam